Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Pediatr Clin North Am. 2008 Feb;55(1):187–xii. doi: 10.1016/j.pcl.2007.10.008

Table 1.

Summary of commonly referenced International Conference on Harmonization (ICH) clinical efficacy guidelines

Document Subject Content
ICH E 2 Adverse Event Reporting Defines terms, timeframes for AE reporting and formatting of AE reports
ICH E 6 GCP Consolidated Guidelines Defines responsibilities of sponsors, investigators, consent process monitoring and auditing procedures, and protection of human subjects
ICH E 9 Statistical Principles Design and conduct of trials intended to support or establish efficacy
ICH E 10 Choice of Control Groups Properties and limitations of different kinds of control groups (active control equivalence, non-inferiority, etc.)
ICH E 11 Clinical Investigations in Pediatric Population Principles of clinical investigations in children, including timing of studies and extrapolation of data relative to studies conducted in adults, consent, assent, and interventions
ICH E 14 Evaluation of QT/QTc Interval Prolongation Testing the effects of new agents on the QT/QTc interval as well as cardiovascular adverse events